NfL as a Potential Biomarker in ATTRv Amyloidosis - European Medical Journal

NfL as a Potential Biomarker in ATTRv Amyloidosis

Neurology
Download PDF

Infographic: NfL as a Potential Biomarker in ATTRv Amyloidosis

Publication of this infographic was supported and reviewed by Alnylam Pharmaceuticals.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given